# Xenios Research Human-Only Blockers — 2026-08-28

> Release boundary: pushed runtime source is frozen at
> `2d662a0d31bb1de9332fb5c591f01cab76b991b1` (tree
> `c1b1c5d64c317b4a26bdbe89735be97fb1b22ca5`). Pushed evidence source is
> frozen at `c01569169cad5e6619187221d84019ae8bfc7c69` (tree
> `c4a48d5d8d5fa159d0234cb0f94c61ca8e87e019`) and differs only in
> `scripts/evidence/routes.public.json`,
> `scripts/evidence/routes-public.test.mjs`, and
> `scripts/release/critical-endpoint-expectations.json`,
> `scripts/evidence/lib/cdp.mjs`,
> `scripts/evidence/network-boundary.test.mjs`,
> `scripts/evidence/capture-synthetic-journeys.mjs`, and
> `scripts/evidence/capture-synthetic-journeys.test.mjs`. The exact-runtime R11
> technical bundle at
> `C:\Users\sboad\AppData\Local\Temp\xenios-gates-2d662a0-r11-volume2-linux\runner-completion.json`
> is PASS at 21/21 gates: assisted production 6 files/115 tests;
> endpoint/static/SEO/Hino 4/79; targeted domains 196/3,116; canonical E2E
> 4/53; full sequential suite 807 files (803 passed/4 skipped) and 12,092
> tests (12,049 passed/43 skipped), zero failures, 469.08s; evidence tooling
> 13 files/208 tests (196 passed/12 skipped), zero failures. Technical packet
> completion and detached review are engineering gates, not human-only
> blockers.

## Qualification

A human-only blocker exists only when every unblocked engineering and review
task is complete and the release still cannot proceed without a specific
external authorization or value. A future capability that is truthfully
disabled, unconfigured, unavailable, or outside this deployment is not a
blocker for this release.

## Current release status: no human GO is requestable yet

The historical bounded db9 preflight smoke is clean at 9/9 HTTP records and 54 browser
captures (30 PASS, 24 PASS_WITH_NOTES, zero failures). It is not the final
matrix. Exact-193 retry1 is `EXCLUDED_EXTERNAL_INTERRUPTION` after Windows
Modern Standby Event 506 at `2026-08-30T18:08:41.172Z` and Event 507 resume at
`2026-08-30T18:14:32.725Z` caused CDP loss. Its 224/1,100 observations were
180 PASS + 44 PASS_WITH_NOTES + 0 FAIL and its targeted partners were 11/11
PASS; no product or harness defect was found, but none is final evidence.

Retry2 completed its primary matrix 1,100/1,100 at 1,023 PASS + 77
PASS_WITH_NOTES + 0 FAIL and its focused gates passed, but it is
`EXCLUDED_EVIDENCE_LIFECYCLE_FLAKE`: synthetic stopped 10/20 on a
service-worker CDP restart. Three valid diagnostics yielded one PASS and two
exact race reproductions, with no product or network failure.

The e641 three-run smoke is excluded at 2 PASS + 1 FAIL. Exact c015 adds only
the canonical synthetic runner and its test beyond e641. Its pinned-toolchain
focused suite passed 53/53, and three prerequisite synthetic runs each passed
20 captures as 18 PASS + 2 declared notes + 0 FAIL with boundary 0 and PII
CLEAN. Retry3 stopped pre-evidence after clone/build and actual 3-suite/23-test
focused PASS because its wrapper assumed one suite. Retry3b passed
network-boundary 23 and routes 17 but stopped pre-preview because its wrapper
assumed a fixed suite total of 3 while Vitest reported describe-block totals 3
then 2. Both guards reset; neither attempt may resume or be reused; neither is
a candidate defect. Retry3c full evidence is sealed: HTTP 100/100; browser
1,100 = 1,023 PASS + 77 expected notes + 0 fail first attempt; focused early,
assisted, negative and unknown 11/11 each and account 99/99, all zero fail and
clean; synthetic 20 = 18 PASS + 2 expected-denial notes + 0 fail; evidence
tests 13 files/213 tests/46 describe suites; release scan 0/0 non-skipped; and
PII CLEAN with 0 findings across 2,332 text / 1,120 PNG manual-review inventory
/ 0 unscannable. Evidence manifest SHA-256 is
`1f90d4fe76f616ed59734256c9188a368227281ae3049c21ce182735b6e2f257`.
The wrapper-only 46-vs-13 stop and excluded fixture-scan attempt remain
disclosed; the reserved-fixture endpoint recapture passed 16/11/0/0 with
config 200. The bounded packet is generated and validated at
`docs/review/xenios-research-full-site-20260829`: 192 files = 191 payload +
inventory self; packet inventory `6dab7745…`; payload inventory `f6ef58ea…`;
manual QA 18 PNG/9 areas/2 viewports with 0 blocking visual and 0 privacy
findings. Canonical release-manifest verification passed under Node
20.19.0/npm 10.8.2 at SHA-256 `16f08fd2…`, binding the packet and
assisted-order environment inventory. Current phase remains
**PACKET_FINALIZING**. The records/evidence successor SHA, exact-final-SHA
checks and origin verification, final RC assignment and detached Codex verdict
do not yet exist. Samuel's production GO is therefore **not yet requestable**.

## Future sole human-only boundary after all engineering closure

| Required action | Authority | Release behaviour until supplied |
| --- | --- | --- |
| A new production GO naming the exact final RC SHA after the validated packet and records are committed as a records/evidence successor, that successor is origin-verified clean, exact-final-SHA checks pass, and detached Codex review passes | Samuel | No deployment. Production remains `3daa3f4aef9d0fcac7fd4ffd941e0b8bdf3dc212` at `dep-da94g05g1s2s7396lkv0`; failed SHA `eb659d8100a3b9831d52688120931c48d10330d9` / `dep-da94b91srm7s73b55dsg` remains disqualified. |

The exact final RC SHA cannot be pre-authorized or inferred from the branch
name. It is established only after the final records/evidence successor commit
exists. Evidence freeze `c0156916…` differs from runtime freeze `2d662a0…` only
in `scripts/evidence/routes.public.json`,
`scripts/evidence/routes-public.test.mjs`, and
`scripts/release/critical-endpoint-expectations.json`,
`scripts/evidence/lib/cdp.mjs`,
`scripts/evidence/network-boundary.test.mjs`,
`scripts/evidence/capture-synthetic-journeys.mjs`, and
`scripts/evidence/capture-synthetic-journeys.test.mjs`. The later packet
successor must add no runtime or evidence-source change beyond that pushed
freeze. No prior GO can be reused.

## Deliberately absent inputs that do not block this release

| Future capability or input | Frozen release disposition |
| --- | --- |
| Tebra scheduling, Patient Portal, telehealth, credentials, practice/provider/location IDs, visit-reason and hours mapping, consent language/approval, sandbox evidence, or activation | **PRODUCTION DISABLED / UNCONFIGURED.** No Tebra credential, identifier, mapping, consent approval, sandbox attestation, environment change, or external account action is part of this deploy. Care shows truthful unavailable/pending states and never fabricates appointment, provider, pharmacy, or portal state. |
| Client-account or invitation migration | No migration ships with this release. Candidate migrations remain unapplied and require a separate future review and authorization. |
| Product or variant activation and private-workbook regeneration | No activation is authorized. Offerings without durable Product Control authority remain request-only, informational, held, or unavailable. |
| Payment, refund, payout, supplier, fulfillment, clinical, or pharmacy effects that lack production authority | Remain production-disabled or explicit unknown/unavailable. Their future credentials, contracts, and approvals are not prerequisites for this code release. |
| Effective public policy/claims copy or an external accessibility audit | Draft or narrowed non-affirmative states remain explicit. A later publication decision is separate from this deploy. |
| Research indexing or public-storefront activation | `RESEARCH_INDEXABLE` and the storefront activation boundary remain off. The reviewed noindex/disabled state is releasable as-is. |
| Git-history rewriting or report renaming | The candidate-tree secret and approved-name scans are the release gates. A cross-branch history rewrite is outside this release and is not required for deployment. |

No credentials, copied secret values, patient-specific URLs, PHI, PII, or
production embed code belong in this document or in the release packet.

## Nonblocking post-release backlog

- Add a durable bounded throttle to the public Tebra configuration GET. Tebra
  remains disabled and the endpoint exposes neither secrets nor clinical
  state, so this defense-in-depth item does not block the safely disabled
  release.
- Production-disabled refund, webhook, catalog-mutation, inventory-aggregate,
  migration, and other future effects remain separate implementation and
  activation work. None is represented as active in this release.

## Closing record

| Field | Value |
| --- | --- |
| Runtime code freeze | `2d662a0d31bb1de9332fb5c591f01cab76b991b1` / `c1b1c5d64c317b4a26bdbe89735be97fb1b22ca5` |
| Evidence freeze | `c01569169cad5e6619187221d84019ae8bfc7c69` / `c4a48d5d8d5fa159d0234cb0f94c61ca8e87e019`; pushed |
| Technical evidence generation | R11 exact-runtime bundle PASS 21/21; exact counts recorded above |
| Historical bounded smoke | db9: HTTP 9/9; browser 54/54 non-failing; not current c015 final validation |
| Current evidence | retry3c FULL_EVIDENCE_SEALED: HTTP 100/100; browser 1,100 = 1,023 PASS + 77 expected notes + 0 fail; focused 11/11, 11/11, 11/11, 11/11 and 99/99 clean; synthetic 20 = 18 + 2 expected denial + 0; evidence tests 13 files/213 tests/46 suites; release scan 0/0 non-skipped; PII CLEAN 0 across 2,332 text / 1,120 PNG manual-review inventory / 0 unscannable; manifest `1f90d4fe…`; packet finalizing |
| Human-only blocker now | NONE — engineering evidence/packet/review remains open, so GO is not requestable |
| Sole human-only blocker after all closure gates pass | Samuel's new GO naming the exact final RC SHA |
| Migration required / authorized / applied | NO / NO / NO |
| Tebra state | PRODUCTION DISABLED / UNCONFIGURED; no credentials, practice/provider/location IDs, mapping, consent approval, sandbox evidence, or activation |
| Production deployed by this packet | NO |
